A detailed history of Violich Capital Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Violich Capital Management, Inc. holds 115,446 shares of ABBV stock, worth $19.4 Million. This represents 3.01% of its overall portfolio holdings.

Number of Shares
115,446
Previous 110,831 4.16%
Holding current value
$19.4 Million
Previous $17.2 Million 22.4%
% of portfolio
3.01%
Previous 2.79%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$159.82 - $182.1 $737,569 - $840,391
4,615 Added 4.16%
115,446 $21 Million
Q4 2023

Jan 26, 2024

BUY
$137.6 - $154.97 $78,019 - $87,867
567 Added 0.51%
110,831 $17.2 Million
Q3 2023

Oct 12, 2023

SELL
$133.59 - $154.65 $731,271 - $846,554
-5,474 Reduced 4.73%
110,264 $16.4 Million
Q2 2023

Jul 25, 2023

SELL
$132.51 - $164.9 $463,784 - $577,150
-3,500 Reduced 2.94%
115,738 $15.6 Million
Q1 2023

Apr 18, 2023

SELL
$144.61 - $166.54 $12,291 - $14,155
-85 Reduced 0.07%
119,238 $19 Million
Q4 2022

Jan 24, 2023

SELL
$138.31 - $165.87 $27,662 - $33,174
-200 Reduced 0.17%
119,323 $19.3 Million
Q3 2022

Oct 17, 2022

SELL
$134.21 - $153.93 $18,252 - $20,934
-136 Reduced 0.11%
119,523 $16 Million
Q2 2022

Jul 25, 2022

SELL
$137.62 - $174.96 $29,175 - $37,091
-212 Reduced 0.18%
119,659 $18.3 Million
Q1 2022

Apr 25, 2022

SELL
$131.98 - $163.75 $132,243 - $164,077
-1,002 Reduced 0.83%
119,871 $19.4 Million
Q4 2021

Jan 26, 2022

BUY
$107.43 - $135.93 $176,400 - $223,197
1,642 Added 1.38%
120,873 $16.4 Million
Q3 2021

Oct 12, 2021

BUY
$106.4 - $120.78 $381,976 - $433,600
3,590 Added 3.1%
119,231 $12.9 Million
Q2 2021

Jul 29, 2021

SELL
$105.21 - $117.21 $310,895 - $346,355
-2,955 Reduced 2.49%
115,641 $13 Million
Q1 2021

Apr 30, 2021

BUY
$102.3 - $112.62 $81,328 - $89,532
795 Added 0.67%
118,596 $12.8 Million
Q4 2020

Jan 29, 2021

BUY
$80.49 - $108.67 $45,074 - $60,855
560 Added 0.48%
117,801 $12.6 Million
Q3 2020

Oct 19, 2020

SELL
$85.91 - $100.83 $590,717 - $693,307
-6,876 Reduced 5.54%
117,241 $10.3 Million
Q2 2020

Aug 03, 2020

BUY
$73.37 - $98.18 $55,394 - $74,125
755 Added 0.61%
124,117 $12.2 Million
Q1 2020

Apr 30, 2020

SELL
$64.5 - $97.79 $54,631 - $82,828
-847 Reduced 0.68%
123,362 $9.4 Million
Q4 2019

Jan 16, 2020

SELL
$72.13 - $90.25 $355,961 - $445,383
-4,935 Reduced 3.82%
124,209 $11 Million
Q3 2019

Nov 06, 2019

SELL
$62.98 - $75.72 $113,049 - $135,917
-1,795 Reduced 1.37%
129,144 $9.78 Million
Q2 2019

Jul 22, 2019

BUY
$65.7 - $83.98 $40,077 - $51,227
610 Added 0.47%
130,939 $0
Q1 2019

May 07, 2019

SELL
$77.14 - $90.79 $177,422 - $208,817
-2,300 Reduced 1.73%
130,329 $10.5 Million
Q4 2018

Feb 12, 2019

SELL
$77.85 - $96.01 $148,615 - $183,283
-1,909 Reduced 1.42%
132,629 $12.2 Million
Q3 2018

Nov 08, 2018

BUY
$88.91 - $98.84 $2.81 Million - $3.13 Million
31,650 Added 30.76%
134,538 $12.7 Million
Q2 2018

Aug 03, 2018

BUY
$89.78 - $106.23 $574,592 - $679,872
6,400 Added 6.63%
102,888 $9.53 Million
Q4 2017

Mar 01, 2018

SELL
$89.56 - $98.21 $6,717 - $7,365
-75 Reduced 0.08%
96,488 $9.33 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $215,906 - $275,779
3,091 Added 3.31%
96,563 $8.58 Million
Q2 2017

Aug 14, 2017

BUY
N/A
93,472
93,472 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Violich Capital Management, Inc. Portfolio

Follow Violich Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Violich Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Violich Capital Management, Inc. with notifications on news.